FI946004A0 - Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio - Google Patents

Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio

Info

Publication number
FI946004A0
FI946004A0 FI946004A FI946004A FI946004A0 FI 946004 A0 FI946004 A0 FI 946004A0 FI 946004 A FI946004 A FI 946004A FI 946004 A FI946004 A FI 946004A FI 946004 A0 FI946004 A0 FI 946004A0
Authority
FI
Finland
Prior art keywords
medical procedure
blood fraction
thrombin
fraction used
thrombin blood
Prior art date
Application number
FI946004A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI946004A (fi
Inventor
Stewart Ant Cederholm-Williams
Ulla Weisfogh
Original Assignee
Squibb & Sons Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Squibb & Sons Inc filed Critical Squibb & Sons Inc
Publication of FI946004A0 publication Critical patent/FI946004A0/fi
Publication of FI946004A publication Critical patent/FI946004A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6429—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/10—Polypeptides; Proteins
    • A61L24/106—Fibrin; Fibrinogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21005—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Surgery (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FI946004A 1992-06-24 1994-12-21 Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio FI946004A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK92830A DK83092D0 (da) 1992-06-24 1992-06-24 Fremgangsmaade til udvinding af thrombin
PCT/GB1993/001323 WO1994000566A1 (fr) 1992-06-24 1993-06-24 Fraction sanguine de thrombine destinee a etre utilisee en traitement medical

Publications (2)

Publication Number Publication Date
FI946004A0 true FI946004A0 (fi) 1994-12-21
FI946004A FI946004A (fi) 1994-12-21

Family

ID=8098037

Family Applications (1)

Application Number Title Priority Date Filing Date
FI946004A FI946004A (fi) 1992-06-24 1994-12-21 Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio

Country Status (12)

Country Link
US (1) US5795571A (fr)
EP (1) EP0654078B1 (fr)
JP (1) JPH07508275A (fr)
AT (1) ATE253631T1 (fr)
AU (1) AU675650B2 (fr)
CA (1) CA2131316C (fr)
DE (1) DE69333286T2 (fr)
DK (2) DK83092D0 (fr)
FI (1) FI946004A (fr)
NO (1) NO944997L (fr)
NZ (2) NZ253294A (fr)
WO (1) WO1994000566A1 (fr)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5585007A (en) * 1994-12-07 1996-12-17 Plasmaseal Corporation Plasma concentrate and tissue sealant methods and apparatuses for making concentrated plasma and/or tissue sealant
US5643192A (en) * 1995-04-06 1997-07-01 Hamilton Civic Hospitals Research Development, Inc. Autologous fibrin glue and methods for its preparation and use
WO2000062828A1 (fr) * 1996-04-30 2000-10-26 Medtronic, Inc. Fibrine autologue d'obturation et ses methodes de fabrication
DE29723807U1 (de) * 1996-04-30 1999-11-04 Medtronic, Inc., Minneapolis, Minn. Autologe Fibrin-Blutstillungsmittel
US6979307B2 (en) * 1997-06-24 2005-12-27 Cascade Medical Enterprises Llc Systems and methods for preparing autologous fibrin glue
US7745106B2 (en) * 1997-06-24 2010-06-29 Cascade Medical Enterprises, Llc Methods and devices for separating liquid components
US6159232A (en) * 1997-12-16 2000-12-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6478808B2 (en) 1997-12-17 2002-11-12 Closys Corporation Clotting cascade initiating apparatus and methods of use and methods of closing wounds
US6274090B1 (en) * 1998-08-05 2001-08-14 Thermogenesis Corp. Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby
US7276235B2 (en) 1998-11-18 2007-10-02 Zlb Behring Gmbh Tissue glue with improved antiadhesive properties
US6447774B1 (en) 1998-11-18 2002-09-10 Aventis Behring Gmbh Stabilized protein preparations for a tissue adhesive
NZ528340A (en) 1998-12-02 2005-07-29 Bristol Myers Squibb Co Spray delivery of cells
US20030069601A1 (en) * 1998-12-15 2003-04-10 Closys Corporation Clotting cascade initiating apparatus and methods of use
EP1180977B1 (fr) 1999-06-01 2011-12-28 Closys Corporation Appareil d'initiation d'une serie de reactions en cascade dans la coagulation sanguine, et procede d'utilisation y relatif
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
US6942880B1 (en) * 2001-04-09 2005-09-13 Medtronic, Inc. Autologous platelet gel having beneficial geometric shapes and methods of making the same
ATE458503T1 (de) * 2001-05-09 2010-03-15 Biointeractions Ltd Wundverschlusssystem und verfahren
US7992725B2 (en) 2002-05-03 2011-08-09 Biomet Biologics, Llc Buoy suspension fractionation system
US7179391B2 (en) 2002-05-24 2007-02-20 Biomet Manufacturing Corp. Apparatus and method for separating and concentrating fluids containing multiple components
US7832566B2 (en) 2002-05-24 2010-11-16 Biomet Biologics, Llc Method and apparatus for separating and concentrating a component from a multi-component material including macroparticles
US20030205538A1 (en) 2002-05-03 2003-11-06 Randel Dorian Methods and apparatus for isolating platelets from blood
US7845499B2 (en) 2002-05-24 2010-12-07 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20060278588A1 (en) 2002-05-24 2006-12-14 Woodell-May Jennifer E Apparatus and method for separating and concentrating fluids containing multiple components
ES2403357T3 (es) 2003-12-11 2013-05-17 Isto Technologies Inc. Sistema de cartílago particulado
US7837708B2 (en) * 2004-04-22 2010-11-23 Arthrex, Inc. Accelerated healing with intraoperative combination of suture and autogenous blood components
US7597687B2 (en) * 2004-10-29 2009-10-06 Spinal Restoration, Inc. Injection of fibrin sealant including an anesthetic in spinal applications
US8124075B2 (en) * 2004-07-16 2012-02-28 Spinal Restoration, Inc. Enhanced biological autologous tissue adhesive composition and methods of preparation and use
US8206448B2 (en) 2004-10-29 2012-06-26 Spinal Restoration, Inc. Injection of fibrin sealant using reconstituted components in spinal applications
US20110213464A1 (en) * 2004-10-29 2011-09-01 Whitlock Steven I Injection of fibrin sealant in the absence of corticosteroids in spinal applications
US7708152B2 (en) 2005-02-07 2010-05-04 Hanuman Llc Method and apparatus for preparing platelet rich plasma and concentrates thereof
US7866485B2 (en) 2005-02-07 2011-01-11 Hanuman, Llc Apparatus and method for preparing platelet rich plasma and concentrates thereof
JP4510898B2 (ja) * 2005-02-07 2010-07-28 ハヌマン リミテッド ライアビリティ カンパニー 血漿濃縮装置
WO2006086199A1 (fr) 2005-02-07 2006-08-17 Hanuman Llc Appareil et procede de preparation de concentres de plasma riche en plaquettes
US7694828B2 (en) * 2005-04-27 2010-04-13 Biomet Manufacturing Corp. Method and apparatus for producing autologous clotting components
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
US8277837B2 (en) 2006-01-11 2012-10-02 Entegrion, Inc. Hemostatic textile
WO2007127834A2 (fr) 2006-04-26 2007-11-08 Medtronic, Inc. Compositions et leurs méthodes d'élaboration
US8567609B2 (en) 2006-05-25 2013-10-29 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
CA2684040C (fr) 2007-04-12 2016-12-06 Isto Technologies, Inc. Procede de formation d'un implant a l'aide d'un moule imitant la forme du site tissulaire defectueux et implant forme a partir de celui-ci
EP2146794B1 (fr) 2007-04-12 2016-10-19 Biomet Biologics, LLC Système de fractionnement de suspension à flotteur
US8328024B2 (en) 2007-04-12 2012-12-11 Hanuman, Llc Buoy suspension fractionation system
EP2620139B1 (fr) 2008-02-27 2016-07-20 Biomet Biologics, LLC Solutions riches d'un antagoniste du récepteur de l'interleukine-1
EP2254991B1 (fr) 2008-02-29 2018-08-22 Biomet Manufacturing, LLC Système et procédé pour la séparation d'une matière
US8012077B2 (en) 2008-05-23 2011-09-06 Biomet Biologics, Llc Blood separating device
US8187475B2 (en) 2009-03-06 2012-05-29 Biomet Biologics, Llc Method and apparatus for producing autologous thrombin
US8313954B2 (en) 2009-04-03 2012-11-20 Biomet Biologics, Llc All-in-one means of separating blood components
US9011800B2 (en) 2009-07-16 2015-04-21 Biomet Biologics, Llc Method and apparatus for separating biological materials
US8591391B2 (en) 2010-04-12 2013-11-26 Biomet Biologics, Llc Method and apparatus for separating a material
US10231721B2 (en) 2010-06-24 2019-03-19 St. Croix Surgical Systems, Llc Failsafe percutaneous wound barrier
US9597425B2 (en) * 2011-10-18 2017-03-21 St. Teresa Medical, Inc. Method of forming a hemostatic product
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
US9642956B2 (en) 2012-08-27 2017-05-09 Biomet Biologics, Llc Apparatus and method for separating and concentrating fluids containing multiple components
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
US10208095B2 (en) 2013-03-15 2019-02-19 Biomet Manufacturing, Llc Methods for making cytokine compositions from tissues using non-centrifugal methods
US9895418B2 (en) 2013-03-15 2018-02-20 Biomet Biologics, Llc Treatment of peripheral vascular disease using protein solutions
US20140271589A1 (en) 2013-03-15 2014-09-18 Biomet Biologics, Llc Treatment of collagen defects using protein solutions
US9950035B2 (en) 2013-03-15 2018-04-24 Biomet Biologics, Llc Methods and non-immunogenic compositions for treating inflammatory disorders
US10143725B2 (en) 2013-03-15 2018-12-04 Biomet Biologics, Llc Treatment of pain using protein solutions
US9550028B2 (en) 2014-05-06 2017-01-24 Biomet Biologics, LLC. Single step desiccating bead-in-syringe concentrating device
US9713810B2 (en) 2015-03-30 2017-07-25 Biomet Biologics, Llc Cell washing plunger using centrifugal force
US9757721B2 (en) 2015-05-11 2017-09-12 Biomet Biologics, Llc Cell washing plunger using centrifugal force
AU2016307447A1 (en) 2015-08-07 2018-02-22 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US10828387B2 (en) 2015-11-12 2020-11-10 St. Teresa Medical, Inc. Method of sealing a durotomy
CA3078625C (fr) 2017-10-09 2023-01-17 Terumo Bct Biotechnologies, Llc Recipient de lyophilisation et son procede d'utilisation
US10953128B2 (en) 2017-11-02 2021-03-23 St. Teresa Medical, Inc. Fibrin sealant products
CA3130668A1 (fr) 2019-03-14 2020-12-03 Terumo Bct Biotechnologies, Llc Recipient de lyophilisation en plusieurs parties et procede d'utilisation

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH259254A (de) * 1945-12-28 1949-01-15 Szent Gyorgyi Albert Dr Verfahren zur Herstellung von Thrombin aus Blut.
US4265233A (en) * 1978-04-12 1981-05-05 Unitika Ltd. Material for wound healing
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
US4374830A (en) * 1979-10-04 1983-02-22 Research Corp. Platelet aggregating material from equine arterial tissue
US4363319A (en) * 1980-06-30 1982-12-14 Applied Medical Devices, Inc. Ready-to-use bandage incorporating a coagulant composition and method of preparing same
US4627879A (en) * 1984-09-07 1986-12-09 The Trustees Of Columbia University In The City Of New York Fibrin adhesive prepared as a concentrate from single donor fresh frozen plasma
US5165938A (en) * 1984-11-29 1992-11-24 Regents Of The University Of Minnesota Wound healing agents derived from platelets
US4696812A (en) * 1985-10-28 1987-09-29 Warner-Lambert Company Thrombin preparations
US4714457A (en) * 1986-09-15 1987-12-22 Robert Alterbaum Method and apparatus for use in preparation of fibrinogen from a patient's blood
DK475386D0 (da) * 1986-10-03 1986-10-03 Weis Fogh Ulla Sivertsen Fremgangsmaade og apparat til fremstilling af biologiske stoffer
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
US4965203A (en) * 1987-01-28 1990-10-23 Warner-Lambert Company Purified thrombin preparations
JPS63243032A (ja) * 1987-03-27 1988-10-07 Green Cross Corp:The トロンビンの加熱処理方法
JPS6440433A (en) * 1987-08-05 1989-02-10 Green Cross Corp Aqueous liquid composition of thrombin
US4752466A (en) * 1987-08-31 1988-06-21 Johnson & Johnson Products, Inc. Thrombin aerosol
DE3734923C1 (de) * 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
US5290552A (en) * 1988-05-02 1994-03-01 Matrix Pharmaceutical, Inc./Project Hear Surgical adhesive material
FR2639958B1 (fr) * 1988-12-06 1992-08-21 Lille Transfusion Sanguine Support biologique pour cultures cellulaires constitue de proteines plasmatiques coagulees par la thrombine, son utilisation pour la culture des keratinocytes, leur recuperation et leur transport a des fins d'utilisation therapeutique
DE3843126C3 (de) * 1988-12-22 1994-10-06 Octapharma Ag Verfahren zur Herstellung eines hochreinen Thrombinkonzentrates
US5219328A (en) * 1990-01-03 1993-06-15 Cryolife, Inc. Fibrin sealant delivery method
US5318524A (en) * 1990-01-03 1994-06-07 Cryolife, Inc. Fibrin sealant delivery kit
US5185001A (en) * 1990-01-18 1993-02-09 The Research Foundation Of State University Of New York Method of preparing autologous plasma fibrin and application apparatus therefor
IE73210B1 (en) * 1990-01-24 1997-05-07 Warner Lambert Co Process for the production of thrombin and high purity thrombin preparation thereby obtained
EP0443724B1 (fr) * 1990-02-20 1999-03-17 Baxter International Inc. Thrombine humaine purifiée et exempte de virus
US5089415A (en) * 1990-09-17 1992-02-18 International Technidyne Corp. Method for clotting heparized blood by the addition of protamine, thrombin and snake venom
AU642987B2 (en) * 1991-03-25 1993-11-04 Warner-Lambert Company Ultra-pure thrombin preparation
EP0505604B1 (fr) * 1991-03-28 1996-09-25 Warner-Lambert Company Préparation de thrombine hautement purifié
FR2679251B1 (fr) * 1991-07-18 1993-11-12 Nord Assoc Essor Transfusion San Procede de preparation d'un concentre de thrombine humaine destine a un usage therapeutique.
EP0534178B1 (fr) * 1991-09-27 2001-04-18 Omrix Biopharmaceuticals S.A. Colle améliorée pour tissus préparée à partir de cryoprécipité
AT396937B (de) * 1992-04-06 1993-12-27 Immuno Ag Verfahren zur aktivierung von blutgerinnungsfaktoren
US5443959A (en) * 1992-09-09 1995-08-22 Tokuyama Corporation Method of assaying fibrinogen, dry reagent therefor, and process for the preparation thereof
US5506127A (en) * 1994-09-21 1996-04-09 Proba; Zbigniew Therapeutic grade thrombin produced by chromatography
US5510102A (en) * 1995-01-23 1996-04-23 The Regents Of The University Of California Plasma and polymer containing surgical hemostatic adhesives

Also Published As

Publication number Publication date
EP0654078B1 (fr) 2003-11-05
NZ253294A (en) 1999-05-28
DK0654078T3 (da) 2004-01-26
DK83092D0 (da) 1992-06-24
AU4350193A (en) 1994-01-24
ATE253631T1 (de) 2003-11-15
WO1994000566A1 (fr) 1994-01-06
DE69333286D1 (de) 2003-12-11
CA2131316A1 (fr) 1994-01-06
AU675650B2 (en) 1997-02-13
CA2131316C (fr) 2002-03-19
NO944997D0 (no) 1994-12-23
DE69333286T2 (de) 2004-08-19
US5795571A (en) 1998-08-18
JPH07508275A (ja) 1995-09-14
EP0654078A1 (fr) 1995-05-24
FI946004A (fi) 1994-12-21
NO944997L (no) 1994-12-23
NZ299131A (en) 2001-07-27

Similar Documents

Publication Publication Date Title
FI946004A (fi) Lääketieteellisessä toimenpiteessä käytettävä trombiiniverifraktio
DE3885300D1 (de) Heilen von wunden.
DE3854424D1 (de) Medizinisches Instrument.
DE3869142D1 (de) System zur infusion von medikamenten.
MY104685A (en) Substituted thiazoles and their use as fungicides.
DE68909902D1 (de) Blutbehandlungseinrichtung des Hohlfasertyps.
DK261490D0 (da) New pharmaceutical compound
DE3850869D1 (de) Blutdruck-Messgerät.
DE69110713D1 (de) 7-Oxabicycloheptan-imidazol-prostaglandin-Analoge, verwendbar bei der Behandlung von thrombotischen und vasospastischen Erkrankungen.
NO871883L (no) Fremgangsmaate for rensing av enkelt- og dobbeltkjedet vevplasminogenaktivator.
ATE124681T1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DE68910973D1 (de) Arzneimittelzusammensetzung, enthaltend deoxyribonukleoside für heilung von wunden.
DK226889A (da) Alkoholpeptidderivat samt anvendelse deraf til mindskning af blodkoagulation
DE59208622D1 (de) Dentalwerkstoffe auf Basis von (Meth)-Acrylaten
DE3787954D1 (de) Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen.
FI885025A (fi) Koagulationshaemmande protein pp4-x, dess framstaellning och anvaendning.
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
GR3005231T3 (fr)
NO882313D0 (no) Desinfeksjonsmiddel og anvendelse av dette for aa desinfisere hud og overflater paa gjenstander.
DK44184D0 (da) Kosmetik
ATE72112T1 (de) Verwendung von 1-benzyl-amino-alkylpyrrolidinonen als antidepressiva.
ATE70971T1 (de) Foerderung der heilung von meniskusgewebe.
ATE96330T1 (de) Heilen von wunden.
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
NO880831D0 (no) Rekombinant human vevsplasminogen-aktivatorblanding.